Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia

Cancer Chemother Rep. 1972 Dec;56(6):729-37.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Blood Cell Count
  • Child
  • Clinical Trials as Topic
  • Daunorubicin / adverse effects
  • Daunorubicin / therapeutic use*
  • Humans
  • Leukemia, Lymphoid / blood
  • Leukemia, Lymphoid / drug therapy*
  • Prednisone / adverse effects
  • Prednisone / therapeutic use*
  • Remission, Spontaneous
  • Time Factors
  • Vincristine / adverse effects
  • Vincristine / therapeutic use*

Substances

  • Vincristine
  • Prednisone
  • Daunorubicin